What is NDC 16714-116?

16714-116 is the product NDC for Rivastigmine, Rivastigmine 9.5 mg/24h patch, extended release, listed with the FDA by Northstar Rx LLC.. It has 1 package NDC, shown above in 10- and 11-digit form.

Northstar Rx LLC., NDC labeler code 16714. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Rivastigmine?

16 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Rivastigmine NDC 16714-116 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)16714-116Labeler and product segments. Claims need a package NDC.

Product NDC at billing width16714-0116Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
16714-116-02	1671401160216714011602	30 POUCH in 1 CARTON (16714-116-02) / 24 h in 1 POUCH (16714-116-01)Marketed from Oct 1, 2019

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Rivastigmine
Generic name (nonproprietary): rivastigmine
Active ingredients: Rivastigmine — 9.5 mg/24h
Dosage form: Patch, Extended release
Route: Transdermal
Labeler: Northstar Rx LLC.NDC labeler code 16714
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 206318
Marketing start: Oct 1, 2019
Listing expires: Dec 31, 2026
Other FDA classes: Cholinesterase Inhibitors (Mechanism)
Identifiers: Product ID 16714-116_eb0de734-0cf3-4e83-b14e-feebe76390e0SPL ID eb0de734-0cf3-4e83-b14e-feebe76390e0SPL set ID 8b809739-8381-4cc1-ab4a-5b17ab902a3dRxCUI 725021, 725023, 1308569UNII PKI06M3IW0UPC 0316714115023, 0316714116020, 0316714117027
Pharmacologic class: Cholinesterase Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Transdermal products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N416714011602 followed by a unit qualifier and the quantity

Package 16714-0116-02. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Oct 30, 2026.

Indications (excerpt from the label)

Rivastigmine transdermal system is an acetylcholinesterase inhibitor indicated for treatment of: Mild, moderate, and severe dementia of the Alzheimer's type (AD) ( 1.1 ) Mild-to-moderate dementia associated with Parkinson's disease (PD) ( 1.2 ) 1.1 Alzheimer’s Disease Rivastigmine transdermal system is indicated for the treatment of dementia of the Alzheimer's type (AD). Efficacy has been demonstrated in patients with mild, moderate, and severe Alzheimer's disease. 1.2 Parkinson’s Disease Dementia Rivastigmine transdermal system is indicated for the treatment of mild-to-moderate dementia associated with Parkinson's disease (PDD).

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 16714-116

What is NDC 16714-116?: 16714-116 is the product NDC for Rivastigmine, Rivastigmine 9.5 mg/24h patch, extended release, listed with the FDA by Northstar Rx LLC.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Rivastigmine.
What is the active ingredient?: Rivastigmine.
Who is the labeler?: Northstar Rx LLC., NDC labeler code 16714. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Rivastigmine?: 16 other product NDCs are listed under this name. See all Rivastigmine NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Rivastigmine NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Rivastigmine	Rivastigmine 13.3 mg/24h	Patch, Extended releaseTransdermal	Northstar Rx LLC.	16714-117	16714-0117-02
Rivastigmine	Rivastigmine 4.6 mg/24h	Patch, Extended releaseTransdermal	Zydus Pharmaceuticals USA Inc.	70710-1196	70710-1196-07
Rivastigmine	Rivastigmine 9.5 mg/24h	Patch, Extended releaseTransdermal	Zydus Pharmaceuticals USA Inc.	70710-1197	70710-1197-07
Rivastigmine	Rivastigmine 13.3 mg/24h	Patch, Extended releaseTransdermal	Zydus Pharmaceuticals USA Inc.	70710-1198	70710-1198-07
Rivastigmine	Rivastigmine 4.6 mg/24h	Patch, Extended releaseTransdermal	Zydus Lifesciences Limited	70771-1949	70771-1949-07
Rivastigmine	Rivastigmine 9.5 mg/24h	Patch, Extended releaseTransdermal	Zydus Lifesciences Limited	70771-1950	70771-1950-07
Rivastigmine	Rivastigmine 13.3 mg/24h	Patch, Extended releaseTransdermal	Zydus Lifesciences Limited	70771-1951	70771-1951-07
Rivastigmine	Rivastigmine 4.6 mg/24h	PatchTransdermal	Mylan Pharmaceuticals Inc.	0378-9070	00378-9070-93
Rivastigmine	Rivastigmine 9.5 mg/24h	PatchTransdermal	Mylan Pharmaceuticals Inc.	0378-9071	00378-9071-93
Rivastigmine	Rivastigmine 13.3 mg/24h	PatchTransdermal	Mylan Pharmaceuticals Inc.	0378-9072	00378-9072-93

All 17 Rivastigmine NDCs

Other NDCs under ANDA 206318

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 206318
Product	Strength	Form · route	Labeler	Product NDC
Rivastigmine	Rivastigmine 13.3 mg/24h	Patch, Extended releaseTransdermal	Northstar Rx LLC.	16714-117
Rivastigmine	Rivastigmine 4.6 mg/24h	Patch, Extended releaseTransdermal	Zydus Pharmaceuticals USA Inc.	70710-1196
Rivastigmine	Rivastigmine 9.5 mg/24h	Patch, Extended releaseTransdermal	Zydus Pharmaceuticals USA Inc.	70710-1197
Rivastigmine	Rivastigmine 13.3 mg/24h	Patch, Extended releaseTransdermal	Zydus Pharmaceuticals USA Inc.	70710-1198
Rivastigmine	Rivastigmine 4.6 mg/24h	Patch, Extended releaseTransdermal	Zydus Lifesciences Limited	70771-1949
Rivastigmine	Rivastigmine 9.5 mg/24h	Patch, Extended releaseTransdermal	Zydus Lifesciences Limited	70771-1950
Rivastigmine	Rivastigmine 13.3 mg/24h	Patch, Extended releaseTransdermal	Zydus Lifesciences Limited	70771-1951